Lab business > Market analysis

Animal research survey suggests more transparency needed

02 August, 2022

While the majority of Australians support the use of animals in research, this support is highly conditional and most agree there needs to be more transparency.

Automation of laboratory accessories opens up new vistas

26 October, 2020 by Smita Deshmukh*

Laboratory accessories have enabled great strides for the life sciences industry, including new developments in drug discovery.

Logistics requirements for a COVID-19 vaccine

08 September, 2020

DHL has published a white paper on delivering stable logistics for vaccines and medical goods during COVID-19 and future health crises.

Aus STEM workforce feels the blow of COVID‑19

25 May, 2020 by Lauren Davis

Australia's research workforce will be severely impacted by the COVID-19 pandemic for an extended period, according to a newly published report.

How to make open innovation work for your company

06 May, 2019

According to Afnan Zafar, collaboration in the field of product development must follow a strict set of rules if firms really want to benefit from open innovation and boost their performance.

Smaller teams produce more innovative research, study finds

14 February, 2019

A new analysis of more than 65 million papers, patents and software projects found that smaller teams produce much more disruptive and innovative research than larger teams.

Australian R&D investment drooping

19 October, 2018

The Australian Government's Science, Research and Innovation (SRI) Budget Tables show that overall investment in research and development is continuing to fall.

UK–US trade deal could threaten the NHS, researchers say

13 July, 2018

The USA's targeting of so-called 'foreign free-riding' in trade deals could lead to a poor deal on pharmaceuticals for the UK post-Brexit.

Gene therapies may not be commercially viable: GlobalData

27 June, 2018

Gene therapies stand to benefit patients immensely, but there are questions about their commercial viability for pharmaceutical companies.

Report: Synthetic biology could be misused to create weapons

21 June, 2018

Although some malicious applications of synthetic biology may not seem plausible right now, they could become achievable with future advances.

Women in STEM: pay improving but opportunities lacking

08 March, 2018

A national survey has revealed that female scientists are not getting the same opportunities for promotion or seniority as their male peers with similar qualifications and experience.

Performance declining for Australia's maths and science students

01 March, 2018

Australia's future is at risk as performance declines amongst our maths and science students, says Science & Technology Australia (STA).

Insights into Australia's clinical trial activity

15 January, 2018

A new report has revealed favourable insights into clinical trials in Australia, where more than $1 billion is invested each year by both government and industry.

In vitro diagnostics market to reach US$69 billion in 2024: GlobalData

13 December, 2017

The overall market value of in vitro diagnostics stands at US$52 billion this year and is projected to grow at a compound annual growth rate of 4.2% to US$69 billion in 2024, according to GlobalData.

More than half of post-surgery antibiotic prescriptions are inappropriate

04 December, 2017

More than half (60%) of antibiotics given to patients after surgery to prevent infections are prescribed inappropriately, usually because they are not required at all — a situation that may be contributing to the rise of antibiotic resistance.

  • All content Copyright © 2023 Westwick-Farrow Pty Ltd